Cargando…

Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience

BACKGROUND: Mycobacterium abscessus infections remain difficult to manage in both cystic fibrosis (CF) and non-CF patients and reported clinical outcomes are largely unsatisfactory. Clinical trial data are limited and no approved therapies are currently available for the management of M abscessus lu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiron, Raphael, Hoefsloot, Wouter, Van Ingen, Jakko, Marchandin, Hélène, Kremer, Laurent, Morisse-Pradier, Hélène, Charriot, Jeremy, Mallet, Jean-Pierre, Herrmann, Jean-Louis, Caimmi, Davide, Moreau, Johan, Dumont, Yann, Godreuil, Sylvain, Bergeron, Anne, Drevait, Margot, Bouzat-Rossigneux, Elodie, Terrail, Nicolas, Andrejak, Claire, Veziris, Nicolas, Grenet, Dominique, Coudrat, Alexandre, Catherinot, Emilie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578164/ https://www.ncbi.nlm.nih.gov/pubmed/36267258 http://dx.doi.org/10.1093/ofid/ofac465

Ejemplares similares

Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
por: Caimmi, Davide, et al.
Publicado: (2018)

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study
por: Henriette Zweijpfenning, Sanne Maria, et al.
Publicado: (2022)

Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study
por: Zweijpfenning, Sanne M.H., et al.
Publicado: (2021)

Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study
por: Veziris, Nicolas, et al.
Publicado: (2021)

Sacroiliitis secondary to catheter-related bacteremia due to Mycobacterium abscessus (sensu stricto)
por: Laurens, Chrislène, et al.
Publicado: (2014)

Metaproteomics to Decipher CF Host-Microbiota Interactions: Overview, Challenges and Future Perspectives
por: Hardouin, Pauline, et al.
Publicado: (2021)

805. Amikacin Liposome Inhalation Suspension (ALIS) Add-on Therapy for Refractory Mycobacterium avium Complex (MAC) Lung Disease: Effect of In Vitro Amikacin Susceptibility on Sputum Culture Conversion
por: Brown-Elliott, Barbara A, et al.
Publicado: (2018)

Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
por: Rubino, Christopher M., et al.
Publicado: (2021)

In-Host Emergence of Linezolid Resistance in a Complex Pattern of Toxic Shock Syndrome Toxin-1-Positive Methicillin-Resistant Staphylococcus aureus Colonization in Siblings with Cystic Fibrosis
por: Boudet, Agathe, et al.
Publicado: (2021)

Quick and wide-range taxonomical repertoire establishment of the cystic fibrosis lung microbiota by tandem mass spectrometry on sputum samples
por: Hardouin, Pauline, et al.
Publicado: (2022)

Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease
por: Rubino, Christopher M., et al.
Publicado: (2021)

Biofilm Formation by Staphylococcus aureus in the Specific Context of Cystic Fibrosis
por: Jean-Pierre, Vincent, et al.
Publicado: (2022)

High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis
por: Menetrey, Quentin, et al.
Publicado: (2020)

Biofilm Formation in Methicillin-Resistant Staphylococcus aureus Isolated in Cystic Fibrosis Patients Is Strain-Dependent and Differentially Influenced by Antibiotics
por: Boudet, Agathe, et al.
Publicado: (2021)

Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo
por: Pearce, Camron, et al.
Publicado: (2020)

DNA Methylation at ATP11A cg11702988 Is a Biomarker of Lung Disease Severity in Cystic Fibrosis: A Longitudinal Study
por: Pineau, Fanny, et al.
Publicado: (2021)

Advances toward the Elucidation of Hypertonic Saline Effects on Pseudomonas aeruginosa from Cystic Fibrosis Patients
por: Michon, Anne-Laure, et al.
Publicado: (2014)

Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus
por: Daniel-Wayman, Shelby, et al.
Publicado: (2019)

Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
por: Schuurbiers, Milou M.F., et al.
Publicado: (2020)

Highly Diversified Pandoraea pulmonicola Population during Chronic Colonization in Cystic Fibrosis
por: Dupont, Chloé, et al.
Publicado: (2017)

Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients’ Lung
por: Menetrey, Quentin, et al.
Publicado: (2021)

Otomastoiditis Caused by Mycobacterium abscessus, the Netherlands
por: van Ingen, Jakko, et al.
Publicado: (2010)

The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease
por: Schildkraut, Jodie A., et al.
Publicado: (2023)

Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China
por: Zhang, Zhijian, et al.
Publicado: (2022)

Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay
por: Portell-Buj, Elena, et al.
Publicado: (2021)

Evaluation of the GenoType NTM-DR assay performance for the identification and molecular detection of antibiotic resistance in Mycobacterium abscessus complex
por: Bouzinbi, Nicolas, et al.
Publicado: (2020)

Mycobacterium riyadhense Pulmonary Infection, France and Bahrain
por: Godreuil, Sylvain, et al.
Publicado: (2012)

Radial‐EBUS and virtual bronchoscopy planner for peripheral lung cancer diagnosis: How it became the first‐line endoscopic procedure
por: Lachkar, Samy, et al.
Publicado: (2022)

Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics
por: Caimmi, Silvia, et al.
Publicado: (2012)

Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial
por: Winthrop, Kevin L., et al.
Publicado: (2021)

Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates
por: Chazel, Marion, et al.
Publicado: (2016)

Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
por: Palucci, Ivana, et al.
Publicado: (2023)

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
por: Sarfati, Sacha, et al.
Publicado: (2022)

Virtual Bronchoscopy Planner and Radial-EBUS Guided Biopsy for Organizing Pneumonia Diagnosis
por: Lachkar, Samy, et al.
Publicado: (2021)

The tough process of unmasking the slow-growing mycobacterium: case report of Mycobacterium microti infection
por: van de Weg, Cornelia A. M., et al.
Publicado: (2019)

Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin
por: Yang, Jeng-How, et al.
Publicado: (2022)

Disseminated Mycobacterium abscessus infection in a peritoneal dialysis patient
por: Mooren, Vincent H.J.F., et al.
Publicado: (2017)

Comparative diffusion assay to assess efficacy of topical antimicrobial agents against Pseudomonas aeruginosa in burns care
por: Aujoulat, Fabien, et al.
Publicado: (2011)

Isolation of Schineria sp. from a Man
por: Roudiere, Laurent, et al.
Publicado: (2007)

RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus
por: Schildkraut, Jodie A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3lrprme6rr0pabp81im2ns1kk9